| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5587238 | Diabetes Research and Clinical Practice | 2017 | 9 Pages |
Abstract
Patients with lower baseline RDWs are more likely to maintain a one-year euglycemia remission after short-term CSII. A faster normalization of glucose during treatment and a lower fasting glucose after therapy are correlated with a long-term glucose control.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Lijuan Xu, Liangjiao Wang, Xinwei Huang, Liehua Liu, Weijian Ke, Xiaoying He, Zhimin Huang, Juan Liu, Xuesi Wan, Xiaopei Cao, Yanbing Li,